Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Refractory Hemorrhagic Cystitis
NCT01561352Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2001
- Primary completion
- Nov 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa in hemorrhagic cystitis (HC), sponsored by Novo Nordisk. Started Sep 2001; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemorrhagic cystitis (HC)
Beyond the preview
Go deeper on NCT01561352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561352.